Ac Immune Sa2025财年第二财季实现净利润-25.65百万美元，同比减少1.95%

市场透视2025-08-11

8月11日，Ac Immune Sa（ACIU.US）公布财报，公告显示公司2025财年第二财季净利润为-25.65百万美元，同比减少1.95%；其中营业收入为1.58百万美元，同比增加108.02%，每股基本收益为-0.25美元。从资产负债表来看，Ac Immune Sa（ACIU.US）总负债1.45亿美元，其中短期债务1.31百万美元，资产负债比为1.65，流动比率为1.34。机构评级：截至...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2558262681?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-11 00:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2558262681","market":"us","top_or_hot":-1,"title":"Ac Immune Sa2025财年第二财季实现净利润-25.65百万美元，同比减少1.95%","media":"市场透视","content":"<div>\n<p>8月11日，Ac Immune Sa（ACIU.US）公布财报，公告显示公司2025财年第二财季净利润为-25.65百万美元，同比减少1.95%；其中营业收入为1.58百万美元，同比增加108.02%，每股基本收益为-0.25美元。从资产负债表来看，Ac Immune Sa（ACIU.US）总负债1.45亿美元，其中短期债务1.31百万美元，资产负债比为1.65，流动比率为1.34。机构评级：截至...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000244a48056d5&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ac Immune Sa2025财年第二财季实现净利润-25.65百万美元，同比减少1.95%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAc Immune Sa2025财年第二财季实现净利润-25.65百万美元，同比减少1.95%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-11 00:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000244a48056d5&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月11日，Ac Immune Sa（ACIU.US）公布财报，公告显示公司2025财年第二财季净利润为-25.65百万美元，同比减少1.95%；其中营业收入为1.58百万美元，同比增加108.02%，每股基本收益为-0.25美元。从资产负债表来看，Ac Immune Sa（ACIU.US）总负债1.45亿美元，其中短期债务1.31百万美元，资产负债比为1.65，流动比率为1.34。机构评级：截至...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000244a48056d5&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ACIU","symbol_name":"AC Immune SA","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000244a48056d5&s=b","article_id":"2558262681","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000244a48056d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2558262681","pubTimestamp":1754841668,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"8月11日，Ac Immune Sa公布财报，公告显示公司2025财年第二财季净利润为-25.65百万美元，同比减少1.95%；其中营业收入为1.58百万美元，同比增加108.02%，每股基本收益为-0.25美元。从资产负债表来看，Ac Immune Sa总负债1.45亿美元，其中短期债务1.31百万美元，资产负债比为1.65，流动比率为1.34。机构评级：截至2025年8月11日，当前有3家机构对Ac Immune Sa目标价做出预测，其中目标均价为9.66美元，其中最低目标价为7.99美元，最高目标价为11.99美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"ACIU":"AC Immune SA"},"translate_title":"Ac Immune Sa achieved net profit of-US $25.65 million in the second fiscal quarter of fiscal year 2025, a year-on-year decrease of 1.95%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACIU":0.9},"content_text":"8月11日，Ac Immune Sa（ACIU.US）公布财报，公告显示公司2025财年第二财季净利润为-25.65百万美元，同比减少1.95%；其中营业收入为1.58百万美元，同比增加108.02%，每股基本收益为-0.25美元。从资产负债表来看，Ac Immune Sa（ACIU.US）总负债1.45亿美元，其中短期债务1.31百万美元，资产负债比为1.65，流动比率为1.34。机构评级：截至2025年8月11日，当前有3家机构对Ac Immune Sa目标价做出预测，其中目标均价为9.66美元，其中最低目标价为7.99美元，最高目标价为11.99美元。公司简介：AC Immune SA 是一家临床阶段的生物制药公司，专注于神经退行性疾病的研究。该公司利用其专有的技术平台来发现、设计和开发针对与蛋白质错误折叠相关的神经退行性疾病的预防、诊断和治疗的新型专有小分子、抗体和疫苗。公司拥有一个业务部门。目前，公司将大部分资源集中在发现和开发针对错误折叠蛋白的治疗和诊断产品上。公司的管线产品包括ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056以及其他产品。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2558262681","isCrawlerRequest":true}